BioWorld Asia

May 27, 1998

View Archived Issues

Interim Pivotal Trial Data Positive For Celltech Leukemia Drug

Read More

Biotech Execs, Financiers Gather At First Forum In Brussels

Read More

ATG Expands Biotech Funding; Invests A$2M In Carbohydrates

Read More

Tumor Suppressor Variance May Boost Cervical Cancer Risk

Read More

Inex, Sequitur Collaborate On Antisense Development

Read More

Cambridge Antibody, Techniclone End Collaboration On Cancer

Read More

TAB In US$8M Pact With Searle For Antibody Drug Development

Read More

Cantab's Herpes Vaccine Positive In Phase I; Phase II Slated For '99

Read More

New Antibody Treatment Aims To Battle Rheumatoid Arthritis

Read More